Bausch + Lomb Corporation (BLCO)
Market Cap | 6.15B |
Revenue (ttm) | 3.77B |
Net Income (ttm) | 58.00M |
Shares Out | 350.00M |
EPS (ttm) | 0.17 |
PE Ratio | 102.41 |
Forward PE | 23.31 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 11,865 |
Open | 17.15 |
Previous Close | 17.41 |
Day's Range | 17.45 - 17.75 |
52-Week Range | 12.20 - 20.20 |
Beta | n/a |
Analysts | Buy |
Price Target | 19.89 (+13.4%) |
Earnings Date | Feb 22, 2023 |
About BLCO
Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. ... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 18 analysts, the average rating for BLCO stock is "Buy." The 12-month stock price forecast is $19.89, which is an increase of 13.40% from the latest price.
News

Bausch + Lomb and Modulight Announce FDA Approval of ML6710i Photodynamic Laser for Use with Bausch + Lomb's VISUDYNE® (Verteporfin for Injection)
VAUGHAN, Ontario & TAMPERE, Finland--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live...

Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2022 Financial Results on February 22
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, will relea...

Bausch + Lomb Introduces Enhanced PreserVision® AREDS 2 Formula Mini Soft Gels with OCUSorb™
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, today anno...

Bausch + Lomb Publishes Update Presentation for the 41st Annual J.P. Morgan Healthcare Conference
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation, (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “Company”), a leading global eye health company dedicated to helping people see better to live ...

Bausch + Lomb Announces Participation at the 41st Annual J.P. Morgan Healthcare Conference
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation, (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, today ann...

Bausch + Lomb and Novaliq Announce Publication of Pivotal Phase 3 Data on NOV03 (Perfluorohexyloctane) in Ophthalmology
VAUGHAN, Ontario & HEIDELBERG, Germany--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to l...

Bausch + Lomb and Glaucoma Research Foundation Announce Launch of Screen, Protect, Cure Campaign In Recognition of Glaucoma Awareness Month
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, and Glauco...

Bausch + Lomb Amends CEO Separation Agreement
VAUGHAN, ON , Dec. 22, 2022 /PRNewswire/ -- Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb" or the "Company"), a leading global eye health company dedicated to helping people see better to...

Bausch + Lomb Receives 510(k) Clearance from FDA for Biotrue® Hydration Boost Contact Lens Rehydrating Drops
Provides Lenses Up to Eight Hours of Moisture* VAUGHAN, ON , Dec. 13, 2022 /PRNewswire/ -- Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb"), a leading global eye health company dedicated t...

Bausch + Lomb's ONE by ONE and Biotrue® Eye Care Recycling Programs Win Gold for Most Environmentally Friendly Service of the Year from Best in Biz Awards
VAUGHAN, ON , Dec. 12, 2022 /PRNewswire/ -- Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb"), a leading global eye health company dedicated to helping people see better to live better, tod...

Bausch + Lomb's Biotrue® Hydration Plus Multi-Purpose Solution Receives Product of the Year Award from Business Intelligence Group's 2022 BIG Awards for Business
VAUGHAN, ON , Nov. 29, 2022 /PRNewswire/ -- Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb"), a leading global eye health company dedicated to helping people see better to live better, tod...

Bausch + Lomb Reports More Than 58 Million Units of Contact Lens, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs
VAUGHAN, ON , Nov. 15, 2022 /PRNewswire/ -- Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb"), a leading global eye health company dedicated to helping people see better to live better, tod...

Bausch + Lomb Announces Participation at the 5th Annual Evercore ISI HealthCONx Conference
VAUGHAN, ON , Nov. 7, 2022 /PRNewswire/ -- Bausch + Lomb Corporation, (NYSE/TSX: BLCO) ("Bausch + Lomb"), a leading global eye health company dedicated to helping people see better to live better, tod...

Bausch + Lomb beats earnings expectations in Q3
Bausch & Lomb Corp. BLCO, +0.63% said Wednesday that it had a loss of $18 million, or 5 cents per share, in the first quarter of 2022, after a gain of $60 million, or 17 cents per share, in the same q...

Bausch + Lomb Announces Third-Quarter 2022 Results
Third-Quarter 2022 Financial Results Revenues of $942 Million GAAP Net Loss Attributable to Bausch + Lomb Corporation of $18 Million Adjusted EBITDA (non-GAAP) 1 of $187 Million GAAP Cash Flow from O...

Bausch + Lomb #LUMIFYEyeDance Challenge Wins 2022 Public Relations and Marketing Excellence Award for External Campaign of the Year from Business Intelligence Group
VAUGHAN, ON , Nov. 1, 2022 /PRNewswire/ -- Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb"), a leading global eye health company dedicated to helping people see better to live better, toda...

Bausch + Lomb Introduces Project Watson™ Health Care Products for Dogs
New Products Will Focus on Dogs' Eyes, Ears and Overall Wellbeing VAUGHAN, ON , Oct. 24, 2022 /PRNewswire/ -- Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb"), a leading global eye health ...

Bausch + Lomb Announces Presentation of Scientific Data and Analyses Evaluating Biotrue® Hydration Plus Multi-Purpose Solution at American Academy of Optometry Annual Meeting
Four Poster Presentations Will Include Research on Company's Latest Solution That Provides More Moisture on Lenses for Patients1 Bausch + Lomb Will Also Sponsor Nine Educational Events VAUGHAN, Ontari...

Bausch + Lomb Will Release Third-Quarter 2022 Financial Results on November 2
VAUGHAN, ON , Oct. 4, 2022 /PRNewswire/ -- Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb"), a leading global eye health company dedicated to helping people see better to live better, will...

Bausch + Lomb Introduces Enhanced Ocuvite® Adult 50+ Eye Vitamin Formulation With Vitamin D
VAUGHAN, ON , Oct. 3, 2022 /PRNewswire/ -- Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb"), a leading global eye health company dedicated to helping people see better to live better, toda...

Bausch + Lomb Will Present Scientific Data and Analyses During World Cornea Congress
One Podium and Two Poster Presentations Will Highlight Pre-Clinical and Clinical Data for Investigational Treatment NOV03, as well as Data from Company's Unique ARMOR Surveillance Study VAUGHAN, ON , ...

Bausch + Lomb Will Present New Scientific Data and Analyses During the American Academy of Ophthalmology Annual Meeting
Bausch + Lomb Will Sponsor Two Educational Events on Dry Eye Disease VAUGHAN, ON , Sept. 26, 2022 /PRNewswire/ -- Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb"), a leading global eye hea...

Bausch + Lomb Announces Webinar for Eye Care Professionals on New AREDS2 Study Findings
VAUGHAN, ON , Sept. 21, 2022 /PRNewswire/ -- Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb"), a leading global eye health company dedicated to helping people see better to live better, to...

Recent Investments By Top Activist Investors Include Bausch + Lomb, Twitter, BBBY & GameStop - Buyers Beware
Activist investors purchase a majority of publicly traded shares in companies they believe need to be improved. It doesn't always work out for the company or its shareholders, so let's examine what in...

First Annual Bausch + Lomb Sponsored Visionary Report Spotlights Nation's 'Blind Spots' on Age-related Macular Degeneration, a Leading Cause of Vision Loss for People 50+
New Report Reveals Vision Loss a Concern for Aging Americans Surveyed, But Majority Are Unaware Age-related Macular Degeneration Is a Leading Cause of Blindness VAUGHAN, Ontario , Sept. 13, 2022 /PRNe...